Divi's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap, Export Incentives and Sale of services for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the ...

Neuland Laboratories Ltd. key Products/Revenue Segments include Active Pharma Ingredients, Sale of services, Export Incentives, Scrap and Other Operating Revenue for the year ending 31-Mar-2024.For ...

Axis Bank is likely to be in the spotlight on Thursday (January 16) as it is set to announce its third-quarter results for FY25. According to CNBC-TV18 poll, the Net Interest Income (NII) of the ...

This page contains programming that requires a scriptable browser. If you have disabled="true" scripting in your browser then you may wish to enable it so that the ...